Program Generally. The Parties will jointly conduct the Program. It is intended that Acuitas will be responsible for the [*], Scribe will be responsible for [*], and Acuitas and Scribe will each [*], in each case as set forth in the Workplan. It is intended that upon completion of the Workplan activities with respect to a Licensed Product, the Parties will have optimized the formulation for such Licensed Product such that GMP activities can be initiated by Scribe upon exercise of an Option with respect to that Licensed Product.
Appears in 2 contracts
Sources: Development and Option Agreement (Scribe Therapeutics, Inc.), Development and Option Agreement (Scribe Therapeutics, Inc.)